Publications in the NUM

Here you will find a list of publications that were written in connection with the Network of University Medicine in the first and second funding phases.

Schwarz T, et al . Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany. Emerging infectious diseases. 2021; 27      [DOI] 
Hoff N-, et al . Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. European Journal of Medical Research. 2021; 2698.      [DOI] 
Arora P, et al . Delta variant (B.1.617.2) sublineages do not show increased neutralization resistance. Cellular & Molecular Immunology. 2021; 182557—2559.      [DOI] 
Baumann M, Berghäuser M, Bolz T, Martens T. Den Fokus neu denken - Skizze eines Pandemiemanagements auf Grundlage der Bedürfnisse und Lern- und Entwicklungserfordernissen von Kindern, Jugendlichen und Familien. 2021;
Holz J. Der Erfolg Vietnams im Kampf gegen das Virus. Südostasien. Zeitschrift für Politik, Kultur, Dialog. 2021 Feb.;
Casagrande M, Fitzek A, Spitzer M, Püschel K, Glatzel M, Krasemann S, Nörz D, Lütgehetmann M, Pfefferle S, Schultheiss M. Detection of SARS-CoV-2 genomic and subgenomic RNA in retina and optic nerve of patients with COVID-19. Br J Ophthalmol. 2021; 105(8):1057-1061.
Hajek A, Bertram F, Heinrich F, Rüth V, Ondruschka B, Kretzler B, Schüler C, Püschel K, König H. Determinants of health care use among homeless individuals: evidence from the Hamburg survey of homeless individuals. BMC Health Services Research. 2021 Apr.; 21(1):317.      [DOI]      [File] 
van Rüth V, König H-, Bertram F, Schmiedel P, Ondruschka B, Püschel K, Heinrich F, Hajek A. Determinants of health-related quality of life among homeless individuals during the COVID-19 pandemic. Public Health. 2021 May; 19460—66.      [DOI]      [File] 
Döpfner M, Habbel C, et al . Die psychische Belastung von Kindern und Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten. Bundesgesundheitsbl. 2021; 64      [DOI] 
Döpfner M, Habbel C, Schulte B, Schulze-Husmann K, Simons M, Heuer F, Wegner C, Bender S, Herpertz-Dahlmann B, Stahl D. Die psychische Belastung von Kindern, Jugendlichen und ihren Familien während der COVID-19-Pandemie und der Zusammenhang mit emotionalen und Verhaltensauffälligkeiten. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2021; 64(12):1522—1532.      [DOI] 
Schuppert A, Polotzek K, Schmitt J, Busse R, Karschau J, Karagiannidis C. Different spreading dynamics throughout Germany during the second wave of the COVID-19 pandemic: A time series study based on national surveillance data. The Lancet Regional Health - Europe. 2021; 6100151.      [DOI]      [File] 
Neumann RJ, Kollmann B, Plichta MM, Lieb K, Tüscher O, Reif A. Differential impact of COVID-related lockdown on mental health in Germany. World Psychiatry. 2021; 20(1):140—141.      [DOI] 
Vanshylla K, et al . Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell host & microbe. 2021;      [DOI] 
Schlickeiser S, Schwarz T, Steiner S, Wittke K, Meyer O, Kalus U, Pruß A, Kurth F, Zoller T, Stahl D. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol. 2021; 11628971.      [DOI] 
Heinrich F, Romich C, Zimmermann T, Kniep I, Fitzek A, Steurer S, Glatzel M, Nörz D, Günther T, Czech-Sioli M, Fischer N, Grundhoff A, Lütgehetmann M, Ondruschka B. Dying of VOC-202012/01 - multimodal investigations in a death case of the SARS-CoV-2 variant. Int J Legal Med. 2021; 1-10.      [DOI] 
Deinhardt-Emmer S, Wittschieber D, Sanft J, Kleemann S, Elschner S, Haupt ea. Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. Elife. 2021; 10
Gieselmann L, et al . Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nature Protocols. 2021;      [DOI] 
Deckert A, Stahl D. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials. 2021; 22(1):      [DOI]      [File] 
Deckert A, et al . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Trials. 2021; 22(1):      [DOI] 
Deckert A, Stahl D. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials. 2021; 22(1):      [DOI]      [File] 
Deckert A, De Allegri M, et al . Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling. Trials. 2021; 22(1):      [DOI] 
Beschoner P, Jarczok M, Kempf M, Weimer K, Geiser F, Hiebel N, Erim Y, Morawa E, Steudte-Schmiedgen S, Jerg-Bretzke L. egePan-VOICE study on the psychosocial burden of the Covid-19 pandemic among medical technical assistants. Z Psychosom Med Psychother. 2021;
Zellmer S, Kahn M, Ebigbo A, et al . Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol. 2021; 59(8):      [DOI] 
Kahn M, Zellmer S, Ebigbo A, et al . Ein Jahr Covid-19: Testung, Verwendung von Schutzausrüstung und Auswirkungen auf die Gastrointestinale Endoskopie in Deutschland. Z Gastroenterol. 2021; 59(12):      [DOI] 
Jensen B, Luebke N, Feldt T, et al . Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. Lancet Reg Health Eur. 2021; 8      [DOI] 
Jensen B, Luebke N, Feldt T, Keitel V, Brandenburger T, Kindgen-Milles D, Lutterbeck M, Freise N, Schoeler D, Haas R, Dilthey A, Walker A, Timm J, Luedde T. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. The Lancet regional health. Europe. 2021; 8100164.      [DOI] 
Jensen B, Luebke N, Feldt T, Keitel V, Brandenburger T, Kindgen-Milles D, Lutterbeck M, Freise NF, Schoeler D, Haas R, Dilthey A, Adams O, Walker A, Timm J, Luedde T. Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany. The Lancet Regional Health- Europe. 2021;      [DOI]      [File] 
Ruhl L, et al . Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks. Signal transduction and targeted therapy. 2021; 6418.      [DOI] 
Stillfried S, Boor P, PANDEMIcs D. Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin. Pathologe. 2021; 1-5.      [DOI] 
Stillfried S, Boor P, PANDEMIcs D. Entwicklung eines kooperativen Obduktionsnetzwerks aus Pathologie, Neuropathologie und Rechtsmedizin. Der Pathologe. 2021 Dec.; 42(2):129—134.      [DOI]      [File] 
Zack F, Nigbur S, Derani H, Boy D, Port A, Büttner A. Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock. Ärzteblatt Mecklenburg-Vorpommern. 2021; 31125—128.     [File] 
Zack F, Nigbur S, Manhart J, Derani H, Boy D, Kolbe V, Büttner A. Erste Ergebnisse der Obduktionen der im Zusammenhang mit den SARS-CoV-2-Infektionen Verstorbenen aus der Unimedizin Rostock. Ärztebl Meckl-Vorpom. 2021; 31125-128.
Revet A, Hebebrand J, Kehoe L, Child C, Bender S, Klauser P. ESCAP CovCAP survey of heads of academic departments to assess the perceived initial (April/May 2020) impact of the COVID-19 pandemic on child and adolescent psychiatry services. European Child & Adolescent Psychiatry. 2021;      [DOI] 
Wagner R, Peterhoff D, Beileke S, et al . Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: The population-based Tirschenreuth study in the hardest-hit German county in spring 2020. Viruses. 2021; 13(6):      [DOI]      [File] 
Jones TC, et al . Estimating infectiousness throughout SARS-CoV-2 infection course. Science (New York, N.Y.). 2021;      [DOI] 
Nörz D, Grunwald M, Olearo F, Fischer N, Aepfelbacher M, Pfefferle S, Lütgehetmann M. Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7. Journal of Clinical Virology. 2021 Aug.; 141104894.      [DOI]      [File] 
Eberhardt KA, et al . Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgG. Microorganisms. 2021; 9      [DOI] 
Korenkov M, Poopalasingam N, Madler M, et al . Evaluation of a Rapid Antigen Test To Detect SARS-CoV-2 Infection and Identify Potentially Infectious Individuals. J Clin Microbiol. 2021; 59(9):      [DOI] 
Toptana T, Eckermann L, Pfeiffer AE, et al . Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?. J Clin Virol. 2021; 135      [DOI] 
Metzendorf M, Featherstone RM. Evaluation of the comprehensiveness, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production. Res Synth Methods. 2021 Jun.;      [DOI] 
Hildebrandt J, Metzendorf MI, Jakob T. Evaluierung der deutschen Datenbank Current Contents Medizin (CC MED) als potenzielle Datenquelle für das Cochrane COVID-19-Studienregister. GMS Med Inform Biom Epidemiol. 2021; 17(3):Doc12.      [DOI]      [File] 
Kruse JM, Zickler D, Lüdemann WM, Piper SK, Gotthardt I, Ihlow J, Greuel S, Horst D, Kahl A, Eckardt K, Elezkurtaj S. Evidence for a thromboembolic pathogenesis of lung cavitations in severely ill COVID-19 patients. Scientific Reports. 2021 Aug.; 11(1):16039.      [DOI]      [File] 
Popp M, Kranke P, Meybohm P, Metzendorf M, Skoetz N, Stegemann MS, Weibel S. Evidence on the efficacy of ivermectin for COVID-19: another story of apples and oranges. BMJ Evid Based Med. 2021; 2021bmjebm-2021-111791.      [DOI] 
Wachinger J, Schirmer M, Täuber N, et al . Experiences with opt-in, at-home screening for SARS-CoV-2 at a primary school in Germany: an implementation study. BMJ Paediatr Open. 2021; 5(1):      [DOI]      [File] 
Tielker JM, Weber JP, Simon ST, Bausewein C, Stiel S, Schneider N. Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLOS ONE. 2021 Jul.; 16(7):e0254056.      [DOI]      [File] 
Tielker JM, Weber J, Simon ST, Bausewein C, Stiel S, Schneider N. Experiences, challenges and perspectives for ensuring end-of-life patient care: A national online survey with general practitioners in Germany. PLoS ONE. 2021; 16(7):e0254056.      [DOI] 
Subbarayan K, Ulagappan K, Wickenhauser C, Seliger B. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues. Current Cancer Drug Targets. 2021 Jul.; 21(5):428—442.      [DOI]      [File] 
Hansen T, Titze U, Kulamadayil-Heidenreich NSA, Glombitza S, Tebbe JJ, Röcken C, Schulz B, Weise M, Wilkens L. First case of postmortem study in a patient vaccinated against SARS-CoV-2. International Journal of Infectious Diseases. 2021 Jun.; 107172—175.      [DOI]      [File] 
Michel P, Savinsky G, Ondruschka B, Czinczoll I. Folgen einer Reanimation in Zeiten der Pandemie. Hamburger Ärzteblatt. 2021; 2021(11):28—30.     [File] 
Muenchhoff M, Graf A, Krebs S, et al . Genomic epidemiology reveals multiple introductions of SARS-CoV-2 followed by community and nosocomial spread, Germany, February to May 2020. Euro Surveill. 2021; 26(43):      [DOI]      [File] 

download